Results 161 to 170 of about 2,000,650 (198)

EBV induced Evans syndrome in a patient of SLE related MAS: A case report. [PDF]

open access: yesMedicine (Baltimore)
Li W, Chen Y, Chen Y, Zhao M, Zhang S.
europepmc   +1 more source

Low Disease Activity State in Juvenile-Onset Systemic Lupus Erythematosus

open access: yesLupus, 2021
Objectives To determine the rate of achieving The Lupus Low Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE) for tracing pertinent treatment modalities. Methods A total of 122 juvenile-onset SLE (jSLE)
Semanur Ozdel   +2 more
exaly   +5 more sources

Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus: A Multicenter Study

open access: yesJoint Bone Spine, 2023
Neuropsychiatric (NP) involvement is a restricted area in juvenile-onset systemic lupus erythematosus (jSLE).To investigate the prevalence, demographic and clinical features, and outcomes of the neurological involvement in the Turkish jSLE population.This study was based upon 24 referral centers' SLE cohorts, multicenter and multidisciplinary network ...
Selçuk Yüksel, Mehmet Yildi̇Z
exaly   +13 more sources

Juvenile-Onset Systemic Lupus Erythematosus (jSLE) – Pathophysiological Concepts and Treatment Options

open access: yesBest Practice and Research in Clinical Rheumatology, 2017
The systemic autoimmune/inflammatory condition systemic lupus erythematosus (SLE) manifests before the age of 16 years in 10-20% of all cases. Clinical courses are more severe, and organ complications are more common in patients with juvenile SLE. Varying gender distribution in different age groups and increasing severity with younger age and the ...
Christian M Hedrich   +2 more
exaly   +3 more sources

Outcome in juvenile onset systemic lupus erythematosus

Current Opinion in Rheumatology, 2005
Over the past 2 decades, there has been a marked improvement in survival among patients with juvenile-onset systemic lupus erythematosus. As a result of the increased life expectancy, children and adolescents with systemic lupus erythematosus are now faced with considerable morbidity resulting from sequelae of disease activity, side effects of ...
RAVELLI, ANGELO   +2 more
openaire   +3 more sources

Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus

Pediatric Drugs, 2002
Systemic lupus erythematosus (SLE) is an inflammatory chronic disease characterized by the presence of activated helper T-cells that induce a B-cell response, resulting in the secretion of pathogenic autoantibodies and the formation of immune complexes.
Luis, Carreño   +3 more
openaire   +2 more sources

Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series

Clinical and Experimental Rheumatology, 2022
Systemic lupus erythematosus (SLE) is a rare multisystem autoimmune disorder with a variable clinical phenotype. Pulmonary hypertension (PHTN) is a recognised (and not uncommonly asymptomatic) complication of the condition with an associated poor prognosis in adults.
Platt, Caroline   +7 more
openaire   +3 more sources

Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus

Annals of the Rheumatic Diseases, 2014
This study tested the concurrent validity of the systemic lupus erythematosus responder index (SRI) in assessing improvement in juvenile-onset systemic lupus erythematosus (jSLE).The SRI considers changes in the SELENA-SLEDAI, BILAG and a 3-cm visual analogue scale of physician-rated disease activity (PGA) to determine patient improvement.
Mina R   +15 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy